239 related articles for article (PubMed ID: 11069620)
1. Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris.
Futei Y; Amagai M; Sekiguchi M; Nishifuji K; Fujii Y; Nishikawa T
J Invest Dermatol; 2000 Nov; 115(5):829-34. PubMed ID: 11069620
[TBL] [Abstract][Full Text] [Related]
2. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.
Sekiguchi M; Futei Y; Fujii Y; Iwasaki T; Nishikawa T; Amagai M
J Immunol; 2001 Nov; 167(9):5439-48. PubMed ID: 11673563
[TBL] [Abstract][Full Text] [Related]
3. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
[TBL] [Abstract][Full Text] [Related]
4. Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules.
Ohyama B; Nishifuji K; Chan PT; Kawaguchi A; Yamashita T; Ishii N; Hamada T; Dainichi T; Koga H; Tsuruta D; Amagai M; Hashimoto T
J Invest Dermatol; 2012 Apr; 132(4):1158-68. PubMed ID: 22277941
[TBL] [Abstract][Full Text] [Related]
5. Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides.
Dworschak J; Recke A; Freitag M; Ludwig RJ; Langenhan J; Kreuzer OJ; Zillikens D; Schmidt E
J Dermatol Sci; 2012 Feb; 65(2):102-9. PubMed ID: 22261006
[TBL] [Abstract][Full Text] [Related]
6. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
[TBL] [Abstract][Full Text] [Related]
7. Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus.
Futei Y; Amagai M; Hashimoto T; Nishikawa T
J Am Acad Dermatol; 2003 Dec; 49(6):1023-8. PubMed ID: 14639380
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
10. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.
Amagai M; Hashimoto T; Shimizu N; Nishikawa T
J Clin Invest; 1994 Jul; 94(1):59-67. PubMed ID: 8040292
[TBL] [Abstract][Full Text] [Related]
11. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
Szabados H; Bősze S; Silló P; Kárpáti S; Hudecz F; Uray K
J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
[TBL] [Abstract][Full Text] [Related]
12. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3).
Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K
Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636
[TBL] [Abstract][Full Text] [Related]
13. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic.
Ding X; Diaz LA; Fairley JA; Giudice GJ; Liu Z
J Invest Dermatol; 1999 May; 112(5):739-43. PubMed ID: 10233765
[TBL] [Abstract][Full Text] [Related]
14. Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies.
Hacker-Foegen MK; Janson M; Amagai M; Fairley JA; Lin MS
J Invest Dermatol; 2003 Dec; 121(6):1373-8. PubMed ID: 14675185
[TBL] [Abstract][Full Text] [Related]
15. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.
Ding X; Aoki V; Mascaro JM; Lopez-Swiderski A; Diaz LA; Fairley JA
J Invest Dermatol; 1997 Oct; 109(4):592-6. PubMed ID: 9326396
[TBL] [Abstract][Full Text] [Related]
16. Cloning of canine desmoglein 3 and immunoreactivity of serum antibodies in human and canine pemphigus vulgaris with its extracellular domains.
Nishifuji K; Amagai M; Ota T; Nishikawa T; Iwasaki T
J Dermatol Sci; 2003 Sep; 32(3):181-91. PubMed ID: 14507443
[TBL] [Abstract][Full Text] [Related]
17. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3).
Memar O; Christensen B; Rajaraman S; Goldblum R; Tyring SK; Brysk MM; McCormick DJ; el-Zaim H; Fan JL; Prabhakar BS
J Immunol; 1996 Oct; 157(7):3171-7. PubMed ID: 8816430
[TBL] [Abstract][Full Text] [Related]
18. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production.
Nishifuji K; Amagai M; Kuwana M; Iwasaki T; Nishikawa T
J Invest Dermatol; 2000 Jan; 114(1):88-94. PubMed ID: 10620121
[TBL] [Abstract][Full Text] [Related]
19. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris.
Müller R; Svoboda V; Wenzel E; Gebert S; Hunzelmann N; Müller HH; Hertl M
Exp Dermatol; 2006 Aug; 15(8):606-14. PubMed ID: 16842599
[TBL] [Abstract][Full Text] [Related]
20. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns.
Parlowsky T; Welzel J; Amagai M; Zillikens D; Wygold T
J Am Acad Dermatol; 2003 Apr; 48(4):623-5. PubMed ID: 12664033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
